- Monday, September 19, 2016 at 12:00PM - 1:30PM
- Room 129
- Open To The Yale Community
- Event URL
- Add to Calendar:
Antibiotics are the cornerstone of modern medicine. Everything from cancer treatment to hip replacements, complex pregnancies to routine throat infections, relies on these “miracle” drugs. This may all change, however. Bacteria are rapidly developing resistance to antibiotics, leaving them ineffective, and there are few new drugs in development. By 2050, antibiotic resistance is predicted to cause 10 million deaths annually at a cost of $100 trillion. This panel will discuss the local, national, and global strategies needed to address antibiotic resistance.
Rachel Cohen, Regional Executive Director of the Drugs for Neglected Diseases initiative, North America.
Steven Hoffman, Associate Professor of Law and Director of the Global Strategy Lab at the University of Ottawa.
Aaron Kesselheim, Associate Professor of Medicine at Harvard Medical School and a faculty member at Brigham and Women’s Hospital.
Moderator - Zain Rizvi YLS '17
Global Health Justice Partnership, Yale Law School and Yale School of Public Health
Center for Global Legal Challenges, Yale Law School
Collaboration for Research Integrity and Transparency (includes Yale Global Health Justice Partnership, the Media Freedom & Information Access Clinic, and the Center for Outcomes Research and Evaluation at Yale-New Haven Hospital)
Department of Internal Medicine, Yale School of Medicine
Department of Epidemiology of Microbial Diseases, Yale School of Public Health
Global Health Leadership Institute, Yale School of Public Health
Solomon Center for Health Law and Policy, Yale Law School
Yale School of Nursing